Mycamine® (micafungin) – Expanded indication
December 20, 2019 - The FDA approved Astellas’s Mycamine (micafungin), for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age.
Top